| Primary |
| Pneumonia |
22.4% |
| Acute Lymphocytic Leukaemia |
13.1% |
| Product Used For Unknown Indication |
11.7% |
| Febrile Neutropenia |
7.0% |
| Antibiotic Prophylaxis |
6.1% |
| Sepsis |
5.2% |
| Pneumonia Aspiration |
4.4% |
| Acute Myocardial Infarction |
4.1% |
| Infection |
2.9% |
| Infectious Peritonitis |
2.9% |
| Infectious Pleural Effusion |
2.9% |
| Hypertension |
2.3% |
| Disseminated Intravascular Coagulation |
2.0% |
| Drug Use For Unknown Indication |
2.0% |
| Influenza |
2.0% |
| Pyelonephritis Acute |
2.0% |
| Blood Pressure |
1.7% |
| Gastroenteritis |
1.7% |
| Postoperative Fever |
1.7% |
| Abdominal Abscess |
1.5% |
|
| Convulsion |
29.8% |
| Pneumonia |
8.3% |
| Platelet Count Increased |
6.0% |
| Pseudomembranous Colitis |
6.0% |
| Hyponatraemia |
4.8% |
| Interstitial Lung Disease |
4.8% |
| Oxygen Saturation Decreased |
4.8% |
| Drug Ineffective |
3.6% |
| Pancytopenia |
3.6% |
| Platelet Count Decreased |
3.6% |
| Renal Failure Acute |
3.6% |
| Acidosis |
2.4% |
| Acute Generalised Exanthematous Pustulosis |
2.4% |
| Alanine Aminotransferase Increased |
2.4% |
| Aspartate Aminotransferase Increased |
2.4% |
| Blood Bilirubin Increased |
2.4% |
| Blood Creatinine Increased |
2.4% |
| Erythema Multiforme |
2.4% |
| Neutrophil Percentage Increased |
2.4% |
| Renal Impairment |
2.4% |
|
| Secondary |
| Pneumonia |
21.5% |
| Pneumonia Aspiration |
14.1% |
| Sepsis |
8.9% |
| Acute Lymphocytic Leukaemia |
5.9% |
| Product Used For Unknown Indication |
5.2% |
| Gastritis |
4.4% |
| Inflammation |
4.4% |
| Interstitial Lung Disease |
4.4% |
| Abdominal Abscess |
3.0% |
| Febrile Neutropenia |
3.0% |
| Gastrointestinal Perforation |
3.0% |
| Huntington's Disease |
3.0% |
| Lower Respiratory Tract Infection |
3.0% |
| Subcutaneous Abscess |
3.0% |
| Ascites |
2.2% |
| Chronic Obstructive Pulmonary Disease |
2.2% |
| Convulsion |
2.2% |
| Fluid Replacement |
2.2% |
| Infectious Peritonitis |
2.2% |
| Local Anaesthesia |
2.2% |
|
| Convulsion |
18.9% |
| Pseudomembranous Colitis |
13.5% |
| Agranulocytosis |
10.8% |
| Pneumonia |
10.8% |
| Drug Ineffective |
5.4% |
| Alanine Aminotransferase Increased |
2.7% |
| Anaemia |
2.7% |
| Aspartate Aminotransferase Increased |
2.7% |
| Blood Bilirubin Increased |
2.7% |
| Condition Aggravated |
2.7% |
| Disseminated Intravascular Coagulation |
2.7% |
| Drug Level Decreased |
2.7% |
| Gallbladder Perforation |
2.7% |
| Gamma-glutamyltransferase Increased |
2.7% |
| Hepatic Enzyme Increased |
2.7% |
| Hepatic Function Abnormal |
2.7% |
| Hyperbilirubinaemia |
2.7% |
| Interstitial Lung Disease |
2.7% |
| Oedema Peripheral |
2.7% |
| Off Label Use |
2.7% |
|
| Concomitant |
| Prophylaxis |
26.0% |
| Pneumonia |
10.5% |
| Product Used For Unknown Indication |
7.4% |
| Myelodysplastic Syndrome |
5.9% |
| Adult T-cell Lymphoma/leukaemia |
4.8% |
| Multiple Myeloma |
4.4% |
| Sepsis |
4.4% |
| Febrile Neutropenia |
4.2% |
| Hypertension |
4.2% |
| Chills |
3.9% |
| Colorectal Cancer |
3.9% |
| Immunosuppression |
2.6% |
| Prophylaxis Against Graft Versus Host Disease |
2.6% |
| Infection Prophylaxis |
2.4% |
| Cancer Pain |
2.2% |
| Insomnia |
2.2% |
| Neutropenia |
2.2% |
| Pneumocystis Jiroveci Pneumonia |
2.2% |
| Infection |
2.0% |
| Nephrogenic Anaemia |
2.0% |
|
| Pneumonia |
12.4% |
| Anaemia |
6.7% |
| Cholangitis |
6.7% |
| Death |
6.7% |
| Renal Impairment |
6.7% |
| White Blood Cell Count Decreased |
6.7% |
| Hyperglycaemia |
5.6% |
| Pyrexia |
5.6% |
| Disseminated Intravascular Coagulation |
4.5% |
| Febrile Neutropenia |
4.5% |
| Hypernatraemia |
4.5% |
| Platelet Count Decreased |
4.5% |
| Sepsis |
4.5% |
| Cor Pulmonale |
3.4% |
| Cytomegalovirus Infection |
3.4% |
| Hypokalaemia |
3.4% |
| Thrombocytopenia |
3.4% |
| Acute Sinusitis |
2.2% |
| Aspartate Aminotransferase Increased |
2.2% |
| Bile Duct Stone |
2.2% |
|
| Interacting |
| Convulsion |
40.0% |
| Pneumonia Aspiration |
20.0% |
| Pneumonia Klebsiella |
20.0% |
| Prophylaxis |
20.0% |
|
| Lung Disorder |
50.0% |
| Multiple Injuries |
50.0% |
|
